These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 15929954

  • 1. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg.
    Martinez FJ, Grossman RF, Zadeikis N, Fisher AC, Walker K, Ambruzs ME, Tennenberg AM.
    Eur Respir J; 2005 Jun; 25(6):1001-10. PubMed ID: 15929954
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S, Breton J, Wynne B.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G.
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [Abstract] [Full Text] [Related]

  • 4. Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
    Grossman RF, Ambrusz ME, Fisher AC, Khashab MM, Kahn JB.
    Clin Ther; 2006 Aug; 28(8):1175-1180. PubMed ID: 16982294
    [Abstract] [Full Text] [Related]

  • 5. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I, Gogos CA, Bassaris H.
    Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
    [Abstract] [Full Text] [Related]

  • 6. A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis media.
    Noel GJ, Blumer JL, Pichichero ME, Hedrick JA, Schwartz RH, Balis DA, Melkote R, Bagchi P, Arguedas A.
    Pediatr Infect Dis J; 2008 Jun; 27(6):483-9. PubMed ID: 18449063
    [Abstract] [Full Text] [Related]

  • 7. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
    Kahn JB, Khashab M, Ambruzs M.
    Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
    [Abstract] [Full Text] [Related]

  • 8. Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial.
    Graham DR, Talan DA, Nichols RL, Lucasti C, Corrado M, Morgan N, Fowler CL.
    Clin Infect Dis; 2002 Aug 15; 35(4):381-9. PubMed ID: 12145720
    [Abstract] [Full Text] [Related]

  • 9. Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin-clavulanate versus azithromycin.
    Guven M, Bulut Y, Sezer T, Aladag I, Eyibilen A, Etikan I.
    Int J Pediatr Otorhinolaryngol; 2006 May 15; 70(5):915-23. PubMed ID: 16293317
    [Abstract] [Full Text] [Related]

  • 10. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D.
    Clin Ther; 1992 May 15; 14(2):214-29. PubMed ID: 1611645
    [Abstract] [Full Text] [Related]

  • 11. Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study.
    Swanson RN, Lainez-Ventosilla A, De Salvo MC, Dunne MW, Amsden GW.
    Treat Respir Med; 2005 May 15; 4(1):31-9. PubMed ID: 15725048
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
    Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD.
    Otolaryngol Head Neck Surg; 2005 Aug 15; 133(2):194-200. PubMed ID: 16087013
    [Abstract] [Full Text] [Related]

  • 13. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
    Romano M, Cuomo A, Gravina AG, Miranda A, Iovene MR, Tiso A, Sica M, Rocco A, Salerno R, Marmo R, Federico A, Nardone G.
    Gut; 2010 Nov 15; 59(11):1465-70. PubMed ID: 20947881
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec 15; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 15. [Infectious exacerbation of chronic obstructive pulmonary disease: prospects for high-dose levofloxacin therapy].
    Astaf'ev AV, Styrt EA, Sinopal'nikov AI.
    Klin Med (Mosk); 2013 Dec 15; 91(3):44-50. PubMed ID: 23789452
    [Abstract] [Full Text] [Related]

  • 16. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
    Petitpretz P, Choné C, Trémolières F, Investigator Study Group.
    Int J Antimicrob Agents; 2007 Jul 15; 30(1):52-9. PubMed ID: 17512704
    [Abstract] [Full Text] [Related]

  • 17. Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae.
    Berry V, Hoover J, Singley C, Woodnutt G.
    Antimicrob Agents Chemother; 2005 Mar 15; 49(3):908-15. PubMed ID: 15728883
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA, Mathew CP, Warner JH, Heyd A, Church D.
    Respir Med; 2000 Nov 15; 94(11):1029-37. PubMed ID: 11127487
    [Abstract] [Full Text] [Related]

  • 19. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Jacobson KD, Guerra FJ.
    Clin Ther; 1992 Nov 15; 14(2):166-77. PubMed ID: 1611641
    [Abstract] [Full Text] [Related]

  • 20. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE, Golden JA, McIver M, Little E, Zurlinden E.
    Int J Antimicrob Agents; 2007 Nov 15; 30(5):422-7. PubMed ID: 17716873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.